Su1757 - Demographic and Clinical Characteristics of Patients Diagnosed with Early-Onset Colorectal Cancer in the Greater Los Angeles Veteran Affairs Healthcare System

2018 ◽  
Vol 154 (6) ◽  
pp. S-579-S-580
Author(s):  
Tina Storage ◽  
Purnima Bharath ◽  
Christine Yu ◽  
Frank Chen ◽  
Anna Betlachin ◽  
...  
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Milena Di Leo ◽  
Raffaella A. Zuppardo ◽  
Marta Puzzono ◽  
Ilaria Ditonno ◽  
Alessandro Mannucci ◽  
...  

2019 ◽  
Vol 89 (6) ◽  
pp. AB398
Author(s):  
Rawan Dayah ◽  
Mohammad Bilal ◽  
Nattapron Tun ◽  
Tewfeek K. Abu-Shami ◽  
Adam L. Booth ◽  
...  

2021 ◽  
Vol 32 ◽  
pp. S575-S576
Author(s):  
J. Soto Alsar ◽  
N. Gutiérrez Alonso ◽  
M. Bringas Beranek ◽  
C. López Jiménez ◽  
A. Gutiérrez Ortiz de la Tabla ◽  
...  

2020 ◽  
Vol 158 (6) ◽  
pp. S-496
Author(s):  
Arif A. Arif ◽  
Daljeet Chahal ◽  
Caroline Speers ◽  
Mary A. De Vera ◽  
Sharlene Gill ◽  
...  

Author(s):  
Jeong Eun Kim ◽  
Jaeyong Choi ◽  
Chang-Ohk Sung ◽  
Yong Sang Hong ◽  
Sun Young Kim ◽  
...  

AbstractThe global incidence of early-onset colorectal cancer (EO-CRC) is rapidly rising. However, the reason for this rise in incidence as well as the genomic characteristics of EO-CRC remain largely unknown. We performed whole-exome sequencing in 47 cases of EO-CRC and targeted deep sequencing in 833 cases of CRC. Mutational profiles of EO-CRC were compared with previously published large-scale studies. EO-CRC and The Cancer Genome Atlas (TCGA) data were further investigated according to copy number profiles and mutation timing. We classified colorectal cancer into three subgroups: the hypermutated group consisted of mutations in POLE and mismatch repair genes; the whole-genome doubling group had early functional loss of TP53 that led to whole-genome doubling and focal oncogene amplification; the genome-stable group had mutations in APC and KRAS, similar to conventional colon cancer. Among non-hypermutated samples, whole-genome doubling was more prevalent in early-onset than in late-onset disease (54% vs 38%, Fisher’s exact P = 0.04). More than half of non-hypermutated EO-CRC cases involved early TP53 mutation and whole-genome doubling, which led to notable differences in mutation frequencies between age groups. Alternative carcinogenesis involving genomic instability via loss of TP53 may be related to the rise in EO-CRC.


Sign in / Sign up

Export Citation Format

Share Document